about
Splice isoforms as therapeutic targets for colorectal cancerActivin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer.HDAC inhibitors repress BARD1 isoform expression in acute myeloid leukemia cells via activation of miR-19a and/or b.Immunohistochemical validation of overexpressed genes identified by global expression microarrays in adrenocortical carcinoma reveals potential predictive and prognostic biomarkersBARD1 mediates TGF-β signaling in pulmonary fibrosis.Expression of oncogenic BARD1 isoforms affects colon cancer progression and correlates with clinical outcome.Expression of an Oncogenic BARD1 Splice Variant Impairs Homologous Recombination and Predicts Response to PARP-1 Inhibitor Therapy in Colon CancerReplication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibilityAntagonizing functions of BARD1 and its alternatively spliced variant BARD1δ in telomere stability.Alternative splicing in cancer: implications for biology and therapy.Common variation at BARD1 results in the expression of an oncogenic isoform that influences neuroblastoma susceptibility and oncogenicity.BARD1 serum autoantibodies for the detection of lung cancer.Whole-exome sequencing identifies rare pathogenic variants in new predisposition genes for familial colorectal cancerDualistic Role of BARD1 in Cancer.
P2860
Q27006500-E79FA5EF-45A4-45FF-8A61-501867767FC0Q33912255-D08AB4AA-FE4B-441E-B327-C713467451EBQ35070712-DFF00ACC-5F8E-4DC2-AD5E-41E9D8D92B22Q35151124-34F8E7D9-7E59-4712-AB3A-B8DF2AA4ECD7Q36105254-9EFAE239-D31C-4F03-8D44-05064AF4F208Q36166792-DA6D7DBC-F59F-4005-9D08-E9373563502FQ36919195-FCCD85D1-29BE-4D95-89FF-991325FDA503Q37026820-E3972E6E-CF4B-49E6-B6F0-89DD188832BBQ37705964-020C94C7-0317-490B-A16B-220F68B0544EQ38179828-75B31974-4C33-4B9E-8FDC-9277ED949CADQ39393433-5751F3D6-B587-42B3-B20B-B2C103F3CE44Q41281453-C50D709B-1F84-43F4-8EDA-55B62086CEAFQ42020935-55C63004-D3E1-403A-8177-64DB88D1D76AQ47177315-DE6023D2-9143-4E3F-B9A7-CDFCF7334305
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
BARD1 expression predicts outcome in colon cancer.
@ast
BARD1 expression predicts outcome in colon cancer.
@en
type
label
BARD1 expression predicts outcome in colon cancer.
@ast
BARD1 expression predicts outcome in colon cancer.
@en
prefLabel
BARD1 expression predicts outcome in colon cancer.
@ast
BARD1 expression predicts outcome in colon cancer.
@en
P2860
P1476
BARD1 expression predicts outcome in colon cancer
@en
P2093
Barbara Jung
Judith C Sporn
P2860
P304
P356
10.1158/1078-0432.CCR-11-0263
P407
P577
2011-06-21T00:00:00Z